P&G Health shares rose over 5% in early trading as the company announced impressive Q2 FY2025 results.
The healthcare giant reported a revenue of ₹313.41 crore, marking a 2.8% increase from ₹304.93 crore in the same quarter last year, despite intense market competition.The net profit for the quarter showed remarkable growth, reaching ₹82.33 crore—a 25.6% increase from ₹65.57 crore in Q2 FY2024.
With resilient performance and strategic growth, P&G Health stock remains a strong contender in the healthcare sector.
As of 9:16 am, P&G Health shares were trading 6.39% higher at Rs 5628.00 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
